Bal Pharma Limited (BOM:524824)
82.28
+0.48 (0.59%)
At close: Nov 6, 2026
Bal Pharma Revenue
Bal Pharma had revenue of 886.16M INR in the quarter ending June 30, 2026, with 34.53% growth. This brings the company's total for the last twelve months to 3.34B, up 13.51% year-over-year. In the fiscal year ending March 31, 2026, Bal Pharma had annual revenue of 3.12B with 2.83% growth. That makes Bal Pharma the 30,263rd largest company in the world by revenue and 2,125th in India.
Revenue (ttm)
3.34B
Revenue Growth
+13.51%
P/S Ratio
0.39
Revenue / Employee
3.56M
Employees
939
Market Cap
1.31B
Revenue by Geography
- Exports 1.90B 61.1%
- India 1.12B 36.1%
- Unallocated 86.82M 2.8%
Fiscal year ended Mar 31, 2026 See the full Bal Pharma breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 3.12B | 85.78M | 2.83% |
| Mar 31, 2025 | 3.03B | -361.36M | -10.65% |
| Mar 31, 2024 | 3.39B | 350.03M | 11.51% |
| Mar 31, 2023 | 3.04B | 230.02M | 8.18% |
| Mar 31, 2022 | 2.81B | 306.86M | 12.25% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Parnax Lab | 2.52B |
| Medico Remedies | 2.38B |
| Lactose (India) | 1.71B |
| Aayush Wellness | 1.62B |
| Makers Laboratories | 1.49B |
| Oxygenta Pharmaceutical | 1.35B |
| Godavari Drugs | 1.11B |
| Coral Laboratories | 967.01M |